NCT03466632

Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy

Randomised Study Comparing the Use of Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 25 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

Detailed description

Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

Conditions

• Colonic Diseases

Interventions

Type	Name	Description
DRUG	Propofol	propofol 1.5 mg/kg slow intravenously, followed by maintenance dose of 0.5 mg/kg/h throughout the procedure.
DRUG	Dexmedetomidine	dexmedetomidine 1 ug/kg over 10 minutes as a bolus dose followed by continuous infusion at a dose of 0.5 ug/kg/h as maintenance dose throughout the procedure

Timeline

• Start date: 2016-04-01
• Primary completion: 2020-04-01
• Completion: 2020-04-01
• First posted: 2018-03-15
• Last updated: 2018-03-15

Locations

1 site across 1 country: Egypt